INOVIO PHARMACEUTICALS, INC. Quarterly Goodwill in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Inovio Pharmaceuticals, Inc. quarterly Goodwill history and growth rate from Q4 2010 to Q4 2023.
  • Inovio Pharmaceuticals, Inc. Goodwill for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$10.5M -100% Dec 31, 2023 10-K 2024-03-06
Q3 2023 $0 -$10.5M -100% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $10.5M $0 0% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.5M $0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $10.5M $0 0% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $10.5M $0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $10.5M $0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $10.5M $0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $10.5M $0 0% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $10.5M $0 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $10.5M $0 0% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $10.5M $0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $10.5M $0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $10.5M $0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $10.5M $0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $10.5M $0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $10.5M $0 0% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $10.5M $0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $10.5M $0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $10.5M $0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $10.5M $0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $10.5M $0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $10.5M $0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $10.5M $0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $10.5M $0 0% Dec 31, 2017 10-K 2019-03-12
Q3 2017 $10.5M $0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $10.5M $0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $10.5M +$400K +3.96% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $10.5M +$400K +3.96% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $10.5M +$400K +3.96% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $10.5M +$400K +3.96% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $10.1M $0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $10.1M $0 0% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $10.1M $0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $10.1M $0 0% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $10.1M $0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $10.1M $0 0% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $10.1M $0 0% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $10.1M $0 0% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $10.1M $0 0% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $10.1M $0 0% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $10.1M $0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $10.1M $0 0% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $10.1M $0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $10.1M $0 0% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $10.1M $0 0% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $10.1M $0 0% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $10.1M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $10.1M $0 0% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $10.1M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $10.1M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 $10.1M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.